Implantation defects in infertile women with endometriosis

Annals of the New York Academy of Sciences

Volumn 955, Issue , 2002, Pages 265-280

  Lessey, Bruce A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Contraception; Endometrium; Implantation; Infertility; Integrins; Osteopontin

Indexed keywords

BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR; ESTROGEN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTEGRIN; LIGAND; OSTEOPONTIN; PROGESTERONE;

CONFERENCE PAPER; CONTRACEPTION; ENDOMETRIOSIS; ENDOMETRIUM; EXTRACELLULAR MATRIX; FEMALE INFERTILITY; FERTILITY; HISTOLOGY; HUMAN; MENSTRUAL CYCLE; NIDATION; OVULATION; PARACRINE SIGNALING; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

EID: 0036213761     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02787.x     Document Type: Conference Paper

References (125)

1. A description of 34 human ova within the first 17 days of development
2. Preparation of the human endometrium for implantation
3. An insight into early reproductive processes through the in vivo model of ovum donation
4. Time of implantation of the conceptus and loss of pregnancy
5. Defective luteal function
6. Aberrant integrin expression in the endometrium of women with endometriosis
7. Hydrosalpinges adversely affect markers of endometrial receptivity
8. Integrins as markers of uterine receptivity in women with primary unexplained infertility
9. The effect of endometriosis on IVF outcome
10. Osteopontin expression during the menstrual cycle in women: Regulation and binding to the endometrial αvβ3 integrin
11. The development of mouse ova under the capsule of the kidney
12. The development of mouse blastocysts transplanted to the scrotal and cryptorchid testis
13. Implantation and development of mouse eggs transferred to the uterus of non-progestational mice
14. Dating the endometrial biopsy
15. Hormonal regulation of the reproductive tract in female mammals
16. Estrogen and progestin receptors in the reproductive tract of male and female primates
17. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle
18. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating
19. Estrogen receptor localization in the female genital tract
20. Progesterone receptor distribution in the human endometrium: Analysis using monoclonal antibodies to the human progesterone receptor
21. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct
22. Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation
23. Paracrine signaling in the endometrium: Integrins and the establishment of uterine receptivity
24. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium
25. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis
26. Immunohistochemical markers of uterine receptivity in the human endometrium
27. Multifaceted roles for IGFBP-1 in human endometrium during implantation and pregnancy
28. Insulin-like growth factor binding protein-1 in female reproductive functions
29. Secretory endometrium synthesizes placental protein 14
30. Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium
31. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles
32. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle
33. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles
34. Factors affecting fertilization: Endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida
35. A role for glycoconjugates in human development: The human feto-embryonic defence system hypothesis
36. The role of leukemia inhibitory factor (LIF) and other cytokines in regulating implantation in mammals
37. Leukemia inhibitory factor: A biological perspective
38. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation
39. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
40. Leukaemia inhibitory factor in human endometrium during the menstrual cycle: Cellular origin and action on production of glandular epithelial cell prostaglandin in vitro
41. Leukemia inhibitory factor (LIF) enhances trophoblast differentiation mediated by human chorionic gonadotropin (hCG)
42. Expression of leukemia inhibitory factor in human endometrium and placenta
43. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggest a potential autocrine paracrine function in regulating embryo implantation
44. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase - An immunohistochemical study
45. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation
46. Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus
47. Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the "window" of implantation
48. erbB genes in the mouse uterus: Cell-specific signaling by epidermal growth factor (EGF) family of growth factors during implantation
49. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor
50. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: A possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
51. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: A possible role in blastocyst implantation
52. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium
53. Effects of epidermal growth factor and transforming growth factor alpha on the mouse trophoblast outgrowth in vitro
54. Localization of epidermal growth factor receptors in first- and third-trimester human placentas
55. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta
56. Expression of epidermal growth factor receptor in the preimplantation uterus and blastocyst of the Western spotted skunk
57. Epidermal growth factor receptor mRNA and protein increase after the four-cell preimplantation stage in murine development
58. The effects of heparin-binding epidermal growth factor-like growth factor on preimplantation-embryo development and implantation in the rat
59. The use of recombinant growth factors to promote human embryo development in serum-free medium
60. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium
61. Integrin adhesion molecules in the human endometrium: Correlation with the normal and abnormal menstrual cycle
62. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy
63. Patterns of expression of integrin molecules in human endometrium throughout the menstrual cycle
64. Differential expression and localization of integrins and CD44 in the membrane domains of human uterine epithelial cells during the menstrual cycle
65. Endometrial integrins and the establishment of uterine receptivity
66. Integrins and human reproduction
67. Integrins and reproductive physiology: Expression and modulation in fertilization, embryogenesis, and implantation
68. Integrins β5, β3, αv are apically distributed in endometrial epithelium
69. 3 integrin expression
70. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: Implications for implantation, contraception, and infertility
71. Distribution of cell adhesion molecules in decidua of early human pregnancy: An immunohistochemical study
72. The effect of hexapeptides on attachment and outgrowth of mouse blastocysts cultured in vitro: Evidence for the involvement of the cell recognition tripeptide Arg-Gly-Asp
73. Molecular interactions between fibronectin and integrins during mouse blastocyst outgrowth
74. Blockade of the αvβ3 integrin adversely affects implantation in the mouse
75. The role of αvβ3 integrin during implantation in the rabbit
76. Extracellular matrix interactions in early human embryos: Implications for normal implantation events
77. 1 integrin in embryo implantation using mouse blastocysts and human decidua
78. Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis
79. The nature and significance of osteopontin
80. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces
81. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)
82. Structure and expression of the mRNA encoding urinary stone protein (osteopontin)
83. Osteopontin: A protein with diverse functions
84. Ovine osteopontin: II. Osteopontin and αvβ3 integrin expression in the uterus and conceptus during the periimplantation period
85. Progesterone modulation of osteopontin gene expression in the ovine uterus
86. Endometrial heparin binding epidermal growth factor (HB-EGF): A paracrine signal for uterine receptivity?
87. Progesterone receptor isoform-B modulates the expression of osteopontin in human endometrial epithelium during the window of implantation
88. Unexplained infertility: Defining the problem and understanding study design
89. Dysregulated expression of ebaf, an occult and novel molecular defect in the endometria of patients with infertility
90. Regulation of HoxA-10 and its expression in normal and abnormal endometrium
91. HOX gene expression is altered in the endometrium of women with endometriosis
92. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility
93. A quantitative evaluation of α1, α4, αv, and β3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle: A flow cytometric appraisal
94. Expression of integrin messenger ribonucleic acid in human endometrium: A quantitative reverse transcription polymerase chain reaction study
95. Integrin expression in normal and out-of-phase endometria
96. Defective endometrial receptivity: An under-appreciated cause of recurrent pregnancy loss
97. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome (PCOS)
98. Medical management of endometriosis and infertility
99. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women
100. Incidence, symptoms, and signs of endometriosis in fertile and infertile women
101. A quantitative overview of controlled trials in endometriosis-associated infertility
102. Surgical treatment of endometriosis-associated infertility: Meta-analysis compared with survival analysis
103. Surgical induction of endometriosis in the rabbit: Effects on fertility and concentration of peritoneal fluid prostaglandins
104. Studies on the surgical induction of endometriosis in the rat
105. Experimental evidence for failure to implant as a mechanism of infertility associated with endometriosis
106. Peritoneal fluid from endometriosis patients affects reproductive outcome in an in vivo model
107. Minimal endometriosis and reduced fecundability: Prospective evidence from an artificial insemination by donor program
108. The pregnancy rate of the no-treatment group in randomized clinical trials of endometriosis therapy
109. Mild and moderate endometriosis: Comparison of treatment modalities for infertile couples
110. Endometriosis: A stage by stage analysis - The role of in vitro fertilization
111. The effect of endometriosis on implantation: Results from the Yale University in vitro fertilization and embryo transfer program
112. Structure and biological activity of basement membrane proteins
113. Laparoscopic surgery in infertile women with minimal or mild endometriosis
114. In vitro inhibition with antiestrogens of estradiol effects on prostaglandin F2 alpha production by human endometrium and endometrial epithelial cells
115. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis
116. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium
117. Peritoneal fluid cytokines and the relationship with endometriosis and pain
118. Improvement in pregnancy rates with GnRH agonist in women with infertility, minimal or mild endometriosis, and aberrant αvβ3 expression: A case-control study
119. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis
120. Immunological aspects of endometriosis
121. The effect of peritoneal fluid from patients with endometriosis on human sperm function in vitro
122. Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: The role of seminal fluid components
123. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis
124. Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: Possible role in infertility associated with endometriosis
125. Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model